Xeris Biopharma Holdings, Inc.
XERS · Healthcare · $1.7B
Pre-market $9.560.00%
Price
$8.28
$9.98
Jul 2, 26Sep 29, 26
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
RevenueOperating IncomeNet Income
9/'26
Revenue$102M+10.3%
6/'26 vs prev quarter
Company Health
Market Cap$1.7B
Operating Margin+10.9%
Cash on Hand$122M7.4% of market cap
Free Cash Flow$65M3.9% of market cap
Short Float 7.5% · biweekly · settled 26.05.15
Among 327 Biotechnology peers
LowMedianHigh
PSR4.9xmedian 11.4xROE+176.3%median -54.5%
